HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.

Abstract
Alzheimer's disease is characterized by the accumulation of β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain. We previously developed [(18)F]fluoropropylcurcumin ([(18)F]FP-curcumin), which demonstrated excellent binding affinity (K(i)=0.07 nM) for Aβ(1-40) aggregates and good pharmacokinetics in normal mouse brains. However, its initial brain uptake was poor (0.52% ID/g at 2 min post-injection). Therefore, in the present study, fluorine-substituted 4,4'-bissubstituted or pegylated curcumin derivatives were synthesized and evaluated. Their binding affinities for Aβ(1-42) aggregates were measured and 1-(4-fluoroethyl)-7-(4'-methyl)curcumin (1) had the highest binding affinity (K(i)=2.12 nM). Fluorescence staining of Tg APP/PS-1 mouse brain sections demonstrated high and specific labeling of Aβ plaques by 1 in the cortex region, which was confirmed with thioflavin-S staining of the same spots in the adjacent brain sections. Radioligand [(18)F]1 was found to have an appropriate partition coefficient (logP(o/w)=2.40), and its tissue distribution in normal mice demonstrated improved brain permeability (1.44% ID/g at 2 min post-injection) compared to that of [(18)F]FP-curcumin by a factor of 2.8 and fast wash-out from mouse brains (0.45% ID/g at 30 min post-injection). These results suggest that [(18)F]1 may hold promise as a PET radioligand for Aβ plaque imaging.
AuthorsIljung Lee, Jehoon Yang, Jung Hee Lee, Yearn Seong Choe
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 21 Issue 19 Pg. 5765-9 (Oct 01 2011) ISSN: 1464-3405 [Electronic] England
PMID21885280 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Ltd. All rights reserved.
Chemical References
  • Amyloid beta-Peptides
  • Fluorine Radioisotopes
  • Peptide Fragments
  • Radiopharmaceuticals
  • amyloid beta-protein (1-42)
  • Curcumin
Topics
  • Alzheimer Disease (diagnostic imaging, metabolism)
  • Amyloid beta-Peptides (chemistry, metabolism)
  • Animals
  • Blood-Brain Barrier (metabolism)
  • Brain (diagnostic imaging, metabolism)
  • Curcumin (analogs & derivatives, chemistry, metabolism, pharmacokinetics)
  • Drug Evaluation, Preclinical
  • Fluorine Radioisotopes (metabolism, pharmacokinetics)
  • Humans
  • Mice
  • Mice, Transgenic
  • Peptide Fragments (chemistry, metabolism)
  • Permeability
  • Plaque, Amyloid (diagnostic imaging, metabolism)
  • Radionuclide Imaging
  • Radiopharmaceuticals (chemical synthesis, chemistry, pharmacokinetics)
  • Sensitivity and Specificity
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: